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In  culture,  fibronectin,  a  440,000-dalton  glycoprotein  produced  by  fibroblasts 
(1-3), monocytes (4,  5), and endothelial  cells  (6-8)  and/or  derived from serum  (9), 
can  bind  to  substratum  and  simultaneously  to  cell  surfaces;  and  thereby promote 
attachment,  spreading,  and  growth  of these  cells  (10,  11).  In  vivo  fibronectin  is 
concentrated  in  areas  of  intense  cellular  activity  during  embryogenesis  (12,  13), 
delayed-type hypersensitivity (14), and wound repair (15-19), suggesting that fibro- 
nectin in vivo may also provide a provisional substratum essential for cell migration 
and proliferation. Nevertheless, little is known of the source of in vivo fibronectin. 
During the first 2  d  after intradermal  antigen challenge in sensitized guinea pigs 
(14)  or excisional skin wounds in guinea pigs (18,  19), a  large quantity of fibronectin 
(14,  18,  19) appeared as fibrillar strands and minute nodular foci in the extravascular 
space both within and adjacent to the damaged tissue as demonstrated by immuno- 
fluorescence. By radioisotopic studies, this interstitial accumulation of fibronectin was 
plasma derived  (14).  In contrast,  fibronectin  accumulation  within  blood  vessels, as 
determined by immunofluorescence, began at  3 d  after tissue injury  (14,  19),  when 
interstitial  deposition  of plasma fibronectin  and  fibrin had  ceased  and  endothelial 
cells within  blood  vessels in  these  tissue sites had  begun  to proliferate.  From  these 
data, we postulated that intravascular fibronectin was produced in situ by endothelial 
cells. Such a hypothesis is quite tenable, in that endothelial cells have been shown to 
synthesize fibronectin in vitro (6-8)  and deposit the fibronectin between themselves 
and the tissue culture dish. In this report we give direct evidence that the blood vessel 
fibronectin is produced in situ and is not plasma derived. 
Materials and Methods 
Experimental System.  (A/J × C47/B16)FI hybrid mice (The Jackson Laboratory, Bar Harbor, 
ME), were thymectomized and, 2-3 wk later, injected  intraperitoneally with rabbit anti-mouse 
thymocyte serum  (Microbiological  Associates,  Walkersville,  MD)  in  doses of 0.25  ml before 
grafting, on the day of grafting, and at 2 and 4 d after graft placement. CD rat (Charles  River 
Breeding Laboratories, Inc., Wilmington, MA) ear skin obtained from the pinna was prepared 
and transplanted as described  previously (20, 21). By 2 wk after grafting, the sites were well- 
healed,  allowing excisional wounds to be made with a 3-mm punch in the center of each graft. 
At various time intervals thereafter, ranging from 2 to  10  d, the wounded  graft sites were 
harvested and bisected  for immunofluorescence and 1-/~m sections. 
Autoradiography of 1-wn Sections.  Mice carrying transplanted rat ear skin on their flanks for 
various numbers of days (2-10) were injected intraperitoneally with 25/zCi of [3H]thymidine  2 
646  J. Exp. MEn. © The Rockefeller  University Press • 0022-1007/82/08/0646/06 $ t .00 
Volume 156  August 1982  646-651 CLARK ET AL  BRIEF DEFINITIVE REPORT  647 
h before killing. Tissue was processed for t-#m sections as previously described (14). In addition, 
the sections were coated with a silver emulsion and incubated for 2 wk before Giemsa staining 
and microscopic examination. Autoradiography of [aH]thymidine incorporation into cell nuclei 
was used to quantitate endothelial cell proliferation. Labeled endothelial cells had >5 grains of 
precipitated silver superimposed on their nuclei.  The percentage of labeled endothelial cells 
was  determined  within  a  0.5-ram swath along the  wound edge from the  epidermis to the 
panniculus carnosis and within the adjacent swath 0.5-1.0 mm from the wound edge. 
Reciprocal Species-specific Anti-Fibronectin Antibodies.  Rat and mouse fibronectin was isolated 
from  normal  rat-  and  mouse-citrated  plasma  using  gelatin-affinity chromatography  (22). 
Fibronectin from each animal was mixed with complete Freund's adjuvant and injected into 
the footpads of reciprocal animals. This procedure produced species-specific antibodies. Antisera 
from each species were purified by adsorption on insolubilized  fibronectin-depleted plasma of 
that  species.  Antibodies were  isolated  by passage of the  antisera over a  protein A  affinity 
column (23) and then conjugated with either fluorescein or rhodamine by the dialysis method 
(24). Immunofluorescence was performed as previously described (14). 
Results 
To test whether blood vessel fibronectin was produced in situ, we used rat ear skin 
transplanted onto the flanks of immunosuppressed mice and reciprocal species-specific 
anti-fibronectin antibodies. Previous studies have shown that donor (rat) blood vessels 
persisted in the xenograft for at least 4 wk after transplantation  (20,  21);  therefore, 
within this time period mouse anti-rat fibronectin antisera would identify fibronectin 
produced  in situ  by donor  (rat)  blood  vessel cells,  while rat  anti-mouse fibronectin 
antisera would identify plasma derived fibronectin deposited in the vessels from the 
recipient  (mouse)  circulation.  Because the  graft sites were healed within  2 wk after 
surgery, it was possible to extirpate a  3-ram punch  biopsy from the center of each 
graft site at that time. 
2 d  after excisional wounding,  the endothelial cells of the microvasculature along 
the wound edge appeared markedly activated as characterized by swollen nuclei with 
an open chromatin pattern, swollen cytoplasm, and bulging of the entire cell into the 
vessel lumen.  Some endothelial  cells  in  blood vessels within  0.5  mm of the wound 
edge demonstrated mitotic figures by day 4. These cytologic findings correlated with 
the  greatly  increased  numbers  of [aH]thymidine-labeled endothelial  cells  near the 
wound  edge  demonstrated  with  1-/tin  section  autoradiography  at  2  and  4  d  after 
injury (Fig.  1). 
When  the  microvasculature near the wound  was examined  with species-specifc, 
fluorescein-labeled, anti-rat fibronectin antibodies, an increased fluorescence of fibro- 
nectin  was  noted  in  the  walls  of blood  vessels that  coursed  within  0.5  mm of the 
wound edge the second day after injury (Fig 2. A and B) compared with the staining 
of fibronectin in walls of rat blood vessels within  the graft before injury  (Fig 2. D). 
When the rat vessels near the wound edge were stained with anti-mouse fibronectin 
no staining was apparent  (Fig 2. C). The lack of vessel fluorescence with anti-mouse 
fibronectin was not secondary to a failure of the anti-mouse fibronectin antibodies to 
stain  mouse  fibronectin  in  tissue  sections,  because  the  microvasculature of normal 
mouse skin fluoresced with  the same anti-mouse antibodies  (Fig 2. E)  but  not with 
anti-rat fibroneetin antibodies (Fig 2. F). Specificity of the antisera was confirmed by 
the  demonstration  that  anti-rat,  but  not  anti-mouse,  fibronectin  antibody-staining 
activity could be abolished  by passage over a  rat-fibronectin  Sepharose 4B  affinity 
column;  conversely,  anti-mouse,  but  not  anti-rat,  fibronectin  staining  could  be 
abrogated by absorption with insolubilized mouse fibronectin. 648  CLARK  ET  AL.  BRIEF  DEFINITIVE REPORT 
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FIG.  1.  Histogram demonstrates marked endothelial cell  proliferation 0-0.5 mm from the wound 
edge within the graft at 2 and 4 d  after extirpation. Each bar and bracket represents the mean + 
standard error of the mean for three mice at each time interval. 
At  the  interface between  transplanted  skin  and  host  skin,  the  microvasculature 
from  the  two  animals  might  intermingle;  therefore,  we  examined  the  graft/host 
interface with our reciprocal anti-rat and anti-mouse fibronectin fluorescent antibody 
probes. At this location, at 2 wk after transplantation, the blood vessels  stained with 
either anti-rat fibronectin (Fig. 3 A) or anti-mouse fibronectin (Fig. 3 B) but not with 
both antibody preparations  (Fig.  3 A  and B). Thus, these data further support the 
hypothesis that fibronectin is synthesized in situ in blood vessels  and that fibronectin 
production is stimulated during microvasculature proliferation in response to injury. 
Discussion 
These studies provide the first clear indication that blood vessels  synthesize fibro- 
nectin in vivo in association with endothelial proliferation. Whereas plasma flbronectin 
can deposit in other sites and bathes the endothelium, we could detect no significant 
recruitment of circulating fibronectin into the matrix of these proliferating vessels, as 
has been shown  in  fibroblast matrices in  vitro  (25).  This suggests  there might  be a 
direct relationship between the observed endothelial proliferation and the increased 
production of fibronectin by cells in the vessel wall. Perhaps the increase in vessel wall 
fibronectin is  an  essential  part  of the  reparative process of blood vessel  basement 
membrane during wound healing or neovascularization. 
Summary 
During the time of tissue repair that ensues subsequent to tissue injury, blood vessel 
wall fibronectin increases concomitantly with endothelial proliferation and angiogen- 
esis. However, the source of this blood vessel  fibronectin had not been delineated. In 
this report we have demonstrated that microvascular fibronectin is produced in situ 
by the proliferating vessels  surrounding excisional wounds. This finding was estab- 
lished by extirpating 3 mm of skin from the center of a well-healed rat xenograph on 
the  flanks  of immunosuppressed  mice, harvesting  the  injured  skin  sites  at  various CLARK  ET  AL.  BRIEF  DEFINITIVE  REPORT  649 
Fie.  2.  Immunofluorescenee studies of small  blood  vessels:  (A)  and  (B)  within  0.5  mm  of an 
excisional wound 2 d after extirpation using fluoreseein-eonjugated anti-rat fibronectin; (C) same as 
(A), using rhodamine-conjugated anti-mouse fibroneetin; (D) in a nonwounded rat graft 2 wk after 
transplantation using fluorescein-conjugated anti-rat fibronectin; (E) in normal mouse skin stained 
with rhodamine-eonjugated anti-mouse fibroneetin; (F) same, with fluoreseein-conjugated anti-rat 
fibronectin. 800 ×. 650  CLARK ET  AL.  BRIEF DEFINITIVE REPORT 
F1o. 3.  Immunofluorescence studies of the rat graft/mouse skin interface at 2 wk after transplan- 
tation with (A) fluorescein-conjugated anti-rat fibronectin or (B) fluorescein-conjugated anti-mouse 
fibronectin. Adjacent tissue specimens are shown in which the rat vessels are indicated by large 
arrows and the mouse vessels  with small arrows. 800 X. 
stages during the healing process, and staining the specimens with reciprocal species- 
specific anti-fibronectin. The proliferating donor vessels that surrounded the wounded 
graft  had  increased  fluorescence  staining  with  FITC  conjugated  mouse  anti-rat 
fibronectin and no staining with rat anti-mouse fibronectin. This finding was taken 
as direct evidence tha[~ the fibronectin was produced in situ by the rat vessels and not 
derived from circulating mouse plasma. 
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